100 related articles for article (PubMed ID: 28296169)
1. Pyrrole-Based Macrocyclic Small-Molecule Inhibitors That Target Oocyte Maturation.
Gunasekaran P; Lee SR; Jeong SM; Kwon JW; Takei T; Asahina Y; Bang G; Kim S; Ahn M; Ryu EK; Kim HN; Nam KY; Shin SY; Hojo H; Namgoong S; Kim NH; Bang JK
ChemMedChem; 2017 Apr; 12(8):580-589. PubMed ID: 28296169
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of a cell-permeable, drug-like small molecule inhibitor targeting the polo-box domain of polo-like kinase 1.
Srinivasrao G; Park JE; Kim S; Ahn M; Cheong C; Nam KY; Gunasekaran P; Hwang E; Kim NH; Shin SY; Lee KS; Ryu E; Bang JK
PLoS One; 2014; 9(9):e107432. PubMed ID: 25211362
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for recognition of Emi2 by Polo-like kinase 1 and development of peptidomimetics blocking oocyte maturation and fertilization.
Jia JL; Han YH; Kim HC; Ahn M; Kwon JW; Luo Y; Gunasekaran P; Lee SJ; Lee KS; Kyu Bang J; Kim NH; Namgoong S
Sci Rep; 2015 Oct; 5():14626. PubMed ID: 26459104
[TBL] [Abstract][Full Text] [Related]
4. Polo-like kinase 1 inhibition results in misaligned chromosomes and aberrant spindles in porcine oocytes during the first meiotic division.
Liao Y; Lin D; Cui P; Abbasi B; Chen C; Zhang Z; Zhang Y; Dong Y; Rui R; Ju S
Reprod Domest Anim; 2018 Feb; 53(1):256-265. PubMed ID: 29143380
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel and selective non-peptide inhibitors targeting the polo-box domain of polo-like kinase 1.
Chen Y; Li Z; Liu Y; Lin T; Sun H; Yang D; Jiang C
Bioorg Chem; 2018 Dec; 81():278-288. PubMed ID: 30170276
[TBL] [Abstract][Full Text] [Related]
6. Novel Macrocyclic Peptidomimetics Targeting the Polo-Box Domain of Polo-Like Kinase 1.
Ryu S; Park JE; Ham YJ; Lim DC; Kwiatkowski NP; Kim DH; Bhunia D; Kim ND; Yaffe MB; Son W; Kim N; Choi TI; Swain P; Kim CH; Lee JY; Gray NS; Lee KS; Sim T
J Med Chem; 2022 Feb; 65(3):1915-1932. PubMed ID: 35029981
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel Polo-like kinase 1 inhibitor that specifically blocks the functions of Polo-Box domain.
Chen Y; Zhang J; Li D; Jiang J; Wang Y; Si S
Oncotarget; 2017 Jan; 8(1):1234-1246. PubMed ID: 27902479
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel peptidomimetics targeting the polo-box domain of polo-like kinase 1.
Li Z; Zhang Z; Sun H; Xu L; Jiang C
Bioorg Chem; 2019 Oct; 91():103148. PubMed ID: 31376784
[TBL] [Abstract][Full Text] [Related]
9. Development of a High-Throughput Assay for Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1 Based on Time-Resolved Fluorescence Energy Transfer.
Kim TG; Lee JH; Lee MY; Kim KU; Lee JH; Park CH; Lee BH; Oh KS
Biol Pharm Bull; 2017; 40(9):1454-1462. PubMed ID: 28867728
[TBL] [Abstract][Full Text] [Related]
10. Polo-like kinase-1 in porcine oocyte meiotic maturation, fertilization and early embryonic mitosis.
Yao LJ; Fan HY; Tong C; Chen DY; Schatten H; Sun QY
Cell Mol Biol (Noisy-le-grand); 2003 May; 49(3):399-405. PubMed ID: 12887092
[TBL] [Abstract][Full Text] [Related]
11. Dynamic and multi-pharmacophore modeling for designing polo-box domain inhibitors.
Sakkiah S; Senese S; Yang Q; Lee KW; Torres JZ
PLoS One; 2014; 9(7):e101405. PubMed ID: 25036740
[TBL] [Abstract][Full Text] [Related]
12. Identification of acylthiourea derivatives as potent Plk1 PBD inhibitors.
Yun T; Qin T; Liu Y; Lai L
Eur J Med Chem; 2016 Nov; 124():229-236. PubMed ID: 27592392
[TBL] [Abstract][Full Text] [Related]
13. Development of Bifunctional Inhibitors of Polo-Like Kinase 1 with Low-Nanomolar Activities Against the Polo-Box Domain.
Scharow A; Knappe D; Reindl W; Hoffmann R; Berg T
Chembiochem; 2016 Apr; 17(8):759-67. PubMed ID: 26634982
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Polo-like kinase 1 in MEK1/2-regulated spindle formation during mouse oocyte meiosis.
Xiong B; Sun SC; Lin SL; Li M; Xu BZ; OuYang YC; Hou Y; Chen DY; Sun QY
Cell Cycle; 2008 Jun; 7(12):1804-9. PubMed ID: 18583944
[TBL] [Abstract][Full Text] [Related]
15. Peptidomimetic Polo-Box-Targeted Inhibitors that Engage PLK1 in Tumor Cells and Are Selective against the PLK3 Tumor Suppressor.
Baxter M; Chapagai D; Craig S; Hurtado C; Varghese J; Nurmemmedov E; Wyatt MD; McInnes C
ChemMedChem; 2020 Jun; 15(12):1058-1066. PubMed ID: 32232973
[TBL] [Abstract][Full Text] [Related]
16. Bora regulates meiotic spindle assembly and cell cycle during mouse oocyte meiosis.
Zhai R; Yuan YF; Zhao Y; Liu XM; Zhen YH; Yang FF; Wang L; Huang CZ; Cao J; Huo LJ
Mol Reprod Dev; 2013 Jun; 80(6):474-87. PubMed ID: 23610072
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1.
Berg A; Berg T
Chembiochem; 2016 Apr; 17(8):650-6. PubMed ID: 26662918
[TBL] [Abstract][Full Text] [Related]
18. Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding Inhibitors.
Zhao XZ; Tsuji K; Hymel D; Burke TR
Molecules; 2019 Apr; 24(8):. PubMed ID: 31014020
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Polo-like kinase-1 in rat oocytes and early embryos implies its functional roles in the regulation of meiotic maturation, fertilization, and cleavage.
Fan HY; Tong C; Teng CB; Lian L; Li SW; Yang ZM; Chen DY; Schatten H; Sun QY
Mol Reprod Dev; 2003 Jul; 65(3):318-29. PubMed ID: 12784254
[TBL] [Abstract][Full Text] [Related]
20. Identification of nitroimidazole-oxime derivatives targeting the polo-box domain of polo-like kinase 1.
Sun J; Liu HY; Xu RF; Zhu HL
Bioorg Med Chem; 2017 Dec; 25(24):6581-6588. PubMed ID: 29100732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
